aldosterone has been researched along with benazepril in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, Y; Inukai, T; Katahira, J; Nakao, K; Takemori, E | 1 |
| Alberti, D; Antiga, L; Bedogna, V; Casagrande, P; Dal Santo, F; Maschio, G; Perobelli, L; Valvo, E; Zamboni, M | 1 |
| Boland, MJ; Cinquegrani, MP; Insel, J; Mirvis, DM; Rubin, SA; Shanes, J; Whalen, JJ | 1 |
| Bauer, JH; Lau, A; Reams, GP | 1 |
| Bellet, M; Corvol, P; Guyene, TT; Ménard, J; Sassano, P; Serrurier, D | 1 |
| Barclay, BW; Lehmann, M; Norman, JA; Zimmerman, MB | 1 |
| Agabiti-Rosei, E; Beschi, M; Boni, E; Castellano, M; Cefis, G; Cerri, B; Muiesan, ML; Pollavini, G; Porcellati, C; Verdecchia, P | 1 |
| Hayasaki-Kajiwara, Y; Iwasaki, T; Nakajima, M; Naya, N; Shimamura, T | 1 |
| Mishina, M; Watanabe, T | 1 |
| Ames, MK; Atkins, CE; Gardner, SY; Lantis, AC | 1 |
| Ames, MK; Atkins, CE; DeFrancesco, TC; Keene, BW; Lantis, AC; Werre, SR | 1 |
| Danhof, M; Fink, M; Giraudel, JM; Mochel, JP; Peyrou, M; Soubret, A | 1 |
| Ames, MK; Atkins, CE; Lantis, AC; Lee, S; zumBrunnen, JR | 1 |
| Desevaux, C; King, JN; Kukk, A; Panteri, A; Seewald, W | 1 |
| Adin, D; Atkins, C; Klein, A; Wallace, G | 1 |
| Domenig, O; Gabriel, V; Guillot, E; Iennarella-Servantez, CA; Mochel, JP; Smith, JS; Sotillo, S; Ward, JL; Yuan, L | 1 |
7 trial(s) available for aldosterone and benazepril
| Article | Year |
|---|---|
A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Chronic Disease; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Multicenter Studies as Topic; Peptidyl-Dipeptidase A; Renin; Time Factors | 1989 |
Crossover design for the dose determination of an angiotensin converting enzyme inhibitor in hypertension.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure Determination; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Renin | 1989 |
Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris.
Topics: Administration, Cutaneous; Aged; Aldosterone; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Epinephrine; Exercise Tolerance; Female; Humans; Male; Middle Aged; Nitroglycerin; Norepinephrine; Renin | 1993 |
Development of hypertension and effects of benazepril hydrochloride in a canine remnant kidney model of chronic renal failure.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Dog Diseases; Dogs; Female; Hypertension; Kidney Failure, Chronic; Male; Renin | 2008 |
Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Diuretics; Dogs; Drug Therapy, Combination; Furosemide; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2015 |
Effect of spironolactone and benazepril on furosemide-induced diuresis and renin-angiotensin-aldosterone system activation in normal dogs.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Diuresis; Diuretics; Dogs; Furosemide; Male; Renin-Angiotensin System; Spironolactone | 2021 |
Dose-response of benazepril on biomarkers of the classical and alternative pathways of the renin-angiotensin-aldosterone system in dogs.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Dogs; Renin-Angiotensin System | 2023 |
9 other study(ies) available for aldosterone and benazepril
| Article | Year |
|---|---|
Effect of benazepril hydrochloride on cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Biomarkers; Blood Pressure; Cardiomegaly; Heart Rate; Hydroxyproline; Hypertension; Male; Muscle Proteins; Myocardium; Norepinephrine; Organ Size; Rats; Rats, Inbred SHR; Renin | 1991 |
Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Drug Evaluation; Electrolytes; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Renin | 1990 |
Effect of benazepril monotherapy in subjects with hypertension associated with renal dysfunction.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Potassium; Renin | 1989 |
Effects of chronic administration of angiotensin converting enzyme (ACE) inhibitors on blood pressure and tissue ACE activity in the SHR.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Enalapril; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Renin | 1987 |
Effects of losartan and benazepril on abnormal circadian blood pressure rhythm and target organ damage in SHRSP.
Topics: Aldosterone; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Cardiomegaly; Circadian Rhythm; Collagen; Heart Rate; Hypertension; Kidney; Losartan; Male; Organ Size; Rats; Rats, Inbred SHR; Renin; Urine | 2002 |
Utility of urinary aldosterone measurement in quantitating RAAS activation.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Diet, Sodium-Restricted; Dogs; Electrolytes; Renin-Angiotensin System | 2012 |
Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Biomarkers; Biotransformation; Dogs; Female; Male; Models, Animal; Models, Biological; Nonlinear Dynamics; Peptidyl-Dipeptidase A; Protein Binding; Renin; Renin-Angiotensin System | 2015 |
Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Body Weight; Dogs; Enalapril; Female; Furosemide; Heart Rate; Male; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Time Factors | 2015 |
Effect of benazepril and robenacoxib and their combination on glomerular filtration rate in dogs.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzazepines; Diphenylamine; Diuretics; Dogs; Drug Interactions; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Kidney; Male; Phenylacetates; Renin; Urodynamics | 2017 |